Errata

Errata

This article corrects:


    The publisher would like to draw the readers’ attention to errors in the following article:

    Brown SA, Barnes C, Curtin J, Dunkley S, Ockelford P, Phillips J, Rowell J, Smith M, Tran H. How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Intern Med J 2012; 42: 12431250.

    Page 1245, first column, first sentence at the beginning of the last paragraph: The sentence currently reads “Prophylactic treatment in patients with haemophilia A or B helps to significantly bleeding reduce episode frequency. …”. It should read as “Prophylactic treatment in patients with haemophilia A or B helps to significantly reduce bleeding episode frequency, …”

    Page 1248: In Reference 8, the symbol is incorrect and should be ®

    ie.Ref 8. Novo Nordisk Australasia. NovoSeven®.RT Australian Approved Product Information. 18 August 2008.

    The publisher apologises for the errors in the article and for any confusion caused.

    Ancillary